[{"AccountsPayableCurrent_0_Q1_USD":9192000.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q1_USD":3861000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-29163000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q1_USD":138000000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q1_USD":40723000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":97257000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":97923000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":692000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":26000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q1_USD":4289000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5459000.0,"MarketableSecuritiesCurrent_0_Q1_USD":97257000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":4000.0,"SecuredDebt_0_Q1_USD":9939000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":41290000.0,"OtherAssetsCurrent_0_Q1_USD":1214000.0,"IncreaseDecreaseInOtherCurrentAssets_1_Q1_USD":368000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-669000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":1129000.0,"InvestmentIncomeInterest_1_Q1_USD":671000.0,"CostOfGoodsAndServicesSoldAmortization_1_Q1_USD":200000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":492000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q1_USD":72343000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1110000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":47923000.0,"RestrictedCashEquivalentsCurrent_0_Q1_USD":567000.0,"ReceivablesNetCurrent_0_Q1_USD":30371000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":33000000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":990000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":39907000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":7304000.0,"OperatingLeasePayments_1_Q1_USD":682000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":5173000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2138000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":569000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":4304000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":0.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":0.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0_Q1_security":17.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":692000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q1_USD":72343000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q1_USD":692000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q1_USD":0.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":990000.0,"AllowanceForDoubtfulAccountsReceivableWriteOffs_1_Q1_USD":0.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":0.0,"NetIncomeLoss_1_Q1_USD":-37654000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-33185000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-6907000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":10929000.0,"LiabilitiesCurrent_0_Q1_USD":60741000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":201580000.0,"Liabilities_0_Q1_USD":275733000.0,"InventoryNet_0_Q1_USD":6002000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-2887000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":3162000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.81,"CommonStockValue_0_Q1_USD":5000.0,"CommonStockSharesOutstanding_0_Q1_shares":46387437.0,"CommonStockSharesIssued_0_Q1_shares":46387437.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":40723000.0,"AssetsCurrent_0_Q1_USD":185378000.0,"Assets_0_Q1_USD":201580000.0,"AdditionalPaidInCapital_0_Q1_USD":1200776000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-666000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":2000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-38323000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1274268000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":46271123.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-3619000.0,"OtherAssetsNoncurrent_0_Q1_USD":514000.0,"ConvertibleDebt_0_Q1_USD":199880000.0,"PrepaidExpenseCurrent_0_Q1_USD":9244000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":11000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":6384000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":7082000.0,"IncreaseDecreaseInInventories_1_Q1_USD":679000.0,"ShareBasedCompensation_1_Q1_USD":5459000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":36433000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":39009000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":9939000.0,"OperatingIncomeLoss_1_Q1_USD":-31580000.0,"InterestPaidNet_1_Q1_USD":4685000.0,"InterestExpense_1_Q1_USD":6756000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":49411000.0,"StockholdersEquity_0_Q1_USD":-74153000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":0.0,"Ticker":"RDUS","CIK":"1428522","name":"RADIUS HEALTH, INC.","OfficialName":"Radius Health Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"368163999.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200507"}]